Frailty and quality of life among older people with and without a cancer diagnosis: Findings from TOPICS-MDS. by Geessink, N.H. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/181910
 
 
 
Please be advised that this information was generated on 2018-04-11 and may be subject to
change.
RESEARCH ARTICLE
Frailty and quality of life among older people
with and without a cancer diagnosis: Findings
from TOPICS-MDS
Noralie Geessink1,2, Yvonne Schoon1,2, Harry van Goor3, Marcel Olde Rikkert1,
Rene´ Melis1,2*, on behalf of the TOPICS-MDS consortium¶
1 Department of Geriatric Medicine, Radboud university medical center, Nijmegen, The Netherlands,
2 Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands,
3 Department of Surgery, Radboud university medical center, Nijmegen, The Netherlands
¶ Membership of the TOPICS-MDS consortium is provided in the Acknowledgments.
* Rene.Melis@radboudumc.nl
Abstract
Background
The number of older cancer patients is rising. Especially in older people, treatment consider-
ations should balance the impact of disease and treatment on quality of life (QOL) and sur-
vival. How a cancer diagnosis in older people interacts with concomitant frailty to impact on
QOL is largely unknown. We aimed to determine the association between frailty and QOL
among community-dwelling older people aged 65 years or above with and without a cancer
diagnosis cross-sectionally and at 12 months follow-up.
Methods
Data were derived from the TOPICS-MDS database. Frailty was quantified by a frailty index
(FI). QOL was measured with the subjective Cantril’s Self Anchoring Ladder (CSAL, range:
0–10) and the health-related EuroQol-5D (EQ-5D, range:-0.33–1.00) at baseline and after
12 months. To determine associations, linear mixed models were used.
Results
7493 older people (78.6±6.4 years, 58.4% female) were included. Dealing with a cancer
diagnosis (n = 751) was associated with worse QOL both at baseline (CSAL:-0.25 (95%-CI:-
0.36;-0.14), EQ-5D:-0.03 (95%-CI:-0.05;-0.02)) and at follow-up (CSAL:-0.13 (95%-CI:-
0.24;-0.02), EQ-5D:-0.02 (95%-CI:-0.03;-0.00)). A ten percent increase in frailty was also
associated with a decrease in QOL at baseline (CSAL:-0.35 (95%-CI:-0.38;-0.32), EQ-5D:-
0.12 (95%-CI:-0.12;-0.11)) and follow-up (CSAL:-0.27 (95%-CI:-0.30;-0.24), EQ-5D:-0.07
(95%-CI:-0.07;-0.06)). When mutually adjusting for frailty and a cancer diagnosis, associa-
tions between a cancer diagnosis and QOL only remained significant for CSAL at baseline
(-0.14 (95%-CI:-0.25;-0.03)), whereas associations between frailty and QOL remained sig-
nificant for all QOL outcomes at baseline and follow-up. No statistical interactions between
cancer and frailty in their combined impact on QOL were found.
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Conclusions
Cancer diagnosis and frailty were associated with worse health-related and self-perceived
QOL both at baseline and at follow-up. Differences in QOL between older people with and
without a cancer diagnosis were explained to a large extent by differences in frailty levels.
This stresses the importance to take into account frailty in routine oncologic care.
Introduction
The number of older patients qualifying for oncologic treatment is rising. Due to concomitant
multi-morbidity and frailty among these patients, physicians need to deal with complex treat-
ment decision-making processes[1–6]. In order to evaluate treatment options, physicians in
oncology care generally focus on short-term complications, morbidity and survival as primary
outcomes[7–9]. Especially in older people with cancer, however, treatment considerations
should be based on individual preferences regarding quality or quantity of life[10–12]. To be
able to balance the impact of disease and treatment on quality of life (QOL) and survival, phy-
sicians should understand how the disease affects individual’s QOL taking into account the
personal context of this patient[13]. Among other factors, patients may greatly differ with
respect to the type and severity of frailty and co-morbidity. A cancer diagnosis has been
reported to relate to worse health-related QOL[14, 15]. Older people with cancer had more
complaints and self-reported diseases compared to older people without cancer[14]. In addi-
tion, people with and without cancer had more complaints with increasing age[14] and the
specific health-related QOL domains impaired also varied with age[15]. Though individual
characteristics among cancer patients such as functional impairment, co-morbidity and psy-
chosocial disabilities have predictive value for QOL[16–19], most studies on the association
between cancer and QOL lack focus on older patients’ frailty. Currently, the interest in frailty
in geriatric oncology is mainly focused on an older person’s ability to cope with the burden of
cancer treatment[20]. Despite the observation that frailty is associated with worse QOL among
older people in general[21–23], the interaction between frailty and a cancer diagnosis in their
combined impact on QOL of older cancer patients is largely unknown (Fig 1). We aimed to
study the differences in the association between frailty and self-perceived and health-related
QOL between community-dwelling older people aged 65 years or above with and without a
cancer diagnosis cross-sectionally and at 12 months follow-up.
Methods
Design
1.1. Data source. The data for this study were derived from The Older Persons and infor-
mal Caregivers Survey Minimum DataSet (TOPICS-MDS) repository[24]. This is a public data
repository which contains information on the physical and mental health being of older per-
sons and informal caregivers across the Netherlands[25]. In total, 60 research projects have
contributed data to this initiative which may have differed in study design, sampling frame-
work, and inclusion criteria. All data were cleaned locally using a standardized protocol.
Anonymized individual-level data were then submitted to a central institution (Radboud uni-
versity medical center, Nijmegen, the Netherlands) for further validation checks and creation
of the pooled dataset[25]. Since TOPICS-MDS is a fully anonymized dataset available for pub-
lic access, no ethical review was needed for our analyses according to Dutch law[25].
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1.2. Inclusion criteria. The following inclusion criteria were utilized to select appropriate
research projects for which TOPICS-MDS data were in the repository:
• Community-dwelling people who were 65 years or older at baseline;
• The study setting was primary care or general population;
• Longitudinal data were available in the separate research project (not necessarily for each
individual within that project) at 12 months follow-up.
1.3. Measures. The primary outcomes were QOL at baseline (cross-sectional analyses)
and QOL after 12 months, respectively. Independent variables of prime interest comprised
frailty and cancer diagnosis. Operational definitions for these variables and measurement can
be found below. Adjustment variables were age, gender and education level.
1.3.1. Quality of life. In the TOPICS-MDS baseline questionnaire for care receivers (T0),
self-perceived and health-related QOL were measured by a modified Cantril’s Self Anchoring
Ladder and the EuroQol-5D, respectively. Both QOL outcomes were also included in the
TOPICS-MDS follow-up questionnaire for care receivers which was gathered after 12 months
(T12).
• Modified Cantril’s Self Anchoring Ladder (CSAL)
CSAL is a one-dimensional index ranging from 0 (completely unsatisfied with life) to 10
(completely satisfied with life) and measures self-perceived general QOL[26]. We used a
modified version of CSAL where respondents were asked to rate their present life on a scale
between zero and ten, without use of the image of a ladder.
• EuroQol-5D (EQ-5D)
The EQ-5D utility score measures health-related QOL[27]. Five dimensions (mobility, self-
care, daily activities, pain and discomfort, anxiety and depression) with three levels each
(1 = no problems, 2 = moderate problems, and 3 = extreme problems) are combined into
one utility score by means of applying the scoring values for the Dutch population[27]. The
EQ-5D utility score ranges from -0.33 to 1.00 where a score below zero is indicative of a
health state worse than death[27].
Fig 1. Interrelations between cancer, frailty, adverse outcomes and quality of life.
https://doi.org/10.1371/journal.pone.0189648.g001
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1.3.2. Frailty. To quantify frailty, frailty indices based on the concept of deficit accumula-
tion were used[28]. Specifically, we used a slightly modified version of the long TOPICS-MDS
frailty index which originally consists of 46 items (TOPICS-FI46) and which can be derived
from the TOPICS-MDS baseline questionnaire[29]. Since the EQ-5D+C was part of the defi-
cits counted in the TOPICS-FI46, we excluded these items to be able to determine the associa-
tion between frailty and QOL as measured with the EQ-5D. In addition, as the cancer
diagnosis was also used as independent variable to differentiate between older people with and
without cancer, this morbidity item was also excluded from the frailty index. Since one item
concerned gender-specific prostate symptoms which, moreover, may be associated with a can-
cer diagnosis, this morbidity item was additionally excluded. Consequently, our adjusted
frailty index consisted of 38 items (TOPICS-FI38). By dividing the number of deficits endorsed
with the number of total deficits included, a frailty index score was calculated that ran from 0
to 1. Whereas theoretically the FI score can be 1 (38 of 38 deficits endorsed), the maximum FI
score observed is usually around 0.6 and 0.7[28]. Participants were considered to be frail when
their TOPICS-FI38 score was equal to or above 0.25.
1.3.3. Cancer diagnosis. In the TOPICS-MDS baseline questionnaire, individuals were
asked to tick boxes which illnesses and conditions they had at the moment or had had in the
past 12 months. To differentiate between people with and without cancer, we used the self-
reported presence of a type of cancer (malignant condition). Beyond this information, no
information on type or severity of cancer was available.
1.3.4. Education level. Since QOL is associated with the education level of people, we
adjusted for education level in our analyses. In the TOPICS-MDS baseline questionnaire, indi-
viduals were asked what the highest level of education was that they had completed as defined
by Verhage[30]. We classified the lowest four levels of education (ranging from less than 6
years primary school to vocational school) as ‘low’, level 5 and 6 (ranging from secondary pro-
fessional education to university entrance level) were classified as ‘moderate’ and level 7 (uni-
versity or tertiary education) was classified as ‘high’.
1.4. Procedure
We used the TOPICS-MDS dataset for care receivers available in January 2017 (version TOP-
ICS_2.0). Based on our inclusion criteria, 14 projects were appropriate to answer our research
question. For these studies, intervention groups were excluded since the interventions may
have influenced respondents’ frailty and/or QOL. Furthermore, respondents living in nursing
homes and respondents with an unknown cancer diagnosis status at baseline were also
excluded. If the respondents’ date of follow-up assessment was outside a 6 months window (3
months before or 3 months after the intended 12 months follow-up), these respondents were
excluded in the analyses. Studies in which the follow-up date was exceeded in more than 60%
of the respondents were excluded as a whole. In the end, 7493 respondents in 11 projects were
included in our analyses (Fig 2).
1.5. Statistical analysis
Demographic characteristics were compared between respondents with and without cancer.
Student’s t-test was used for continuous data and the chi-square test was used to compare cate-
gorical data. The proportions of frailty deficits endorsed among frail respondents with cancer
were compared with those among frail respondents without cancer and were considered clini-
cally relevant if the proportions differed by 5%. To determine the association between frailty
and QOL, we used linear mixed models to account for clustering within individual research
Frailty and quality of life among older people with and without a cancer diagnosis
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projects. Independent variables included age, sex, education level, frailty, cancer diagnosis sta-
tus, the interaction term frailtycancer diagnosis and (for the longitudinal analyses) the score
on the respective QOL measure at T0. Associations with the primary determinants were exam-
ined in unadjusted models as well as models adjusted for age, sex and education level. Data
were analyzed using the statistical software program SPSS version 22.
Results
Sample characteristics
In total, 7493 respondents were included in this study. Significant differences in age, frailty
and outcome variables existed between included respondents and excluded respondents (S1
Table). Of the included respondents, 10.0% (n = 751) reported to have cancer at the moment
of the baseline measurement or to have had cancer in the 12 months prior to the baseline
assessment. The majority had no missing data points for TOPICS-FI38: 99.2% (n = 7433),
Fig 2. Flowchart included TOPICS-MDS studies. FU = Follow-up.
https://doi.org/10.1371/journal.pone.0189648.g002
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CSAL: 98.4% (n = 7371), and EQ-5D: 98.5% (n = 7379). Among respondents without cancer,
the majority was female (59.4%) contrary to respondents with cancer (49.7%, p<0.001). Age
was comparable between both groups (Table 1). Respondents with cancer were significantly
more frail compared to respondents without cancer (TOPICS-FI38: 0.23±0.13 and 0.20±0.13,
p<0.001, respectively) and QOL was rated significantly worse both at baseline (CSAL: 6.9±1.4
and 7.2±1.5, p<0.001. EQ-5D: 0.73±0.2 and 0.77±0.2, p<0.001) and at follow-up (CSAL: 6.8±
1.4 and 7.1±1.5, p<0.001. EQ-5D: 0.71±0.3 and 0.76±0.2, p<0.001).
Analysis of the differences in deficits between frail respondents with and without cancer (Fig
3) showed that frail respondents with cancer had more benign prostate hypertrophy (13 vs. 7%,
mean difference: -0.06, 95%-CI: -0.10; -0.01), more depression (24 vs. 19%, mean difference:
-0.05, 95%-CI:-0.10; 0.00), more heart failure (39 vs. 30%, mean difference: -0.09, 95%-CI: -0.15;
-0.03), more dizziness with falling (41 vs. 31%, mean difference: -0.10, 95%-CI: -0.16; -0.04),
more hearing disorders (59 vs. 52%, mean difference: -0.07, 95%-CI: -0.13; -0.00), and they felt
more unhealthy (81 vs. 72%, mean difference: -0.09, 95%-CI: -0.15; -0.04). Frail respondents
without cancer had more dementia (19 vs. 14%, mean difference: -0.06, 95%-CI: -0.01; -0.10).
Outcomes
Univariable analyses showed that CSAL and EQ-5D scores at baseline and follow-up, in addi-
tion to being related to frailty and cancer diagnosis, were significantly higher in respondents
who were younger, and higher educated. For the EQ-5D at baseline and at follow-up, also males
scored significantly higher in univariable analyses (S2 Table). Adjusted for age, gender, educa-
tion level and baseline QOL score if appropriate, a cancer diagnosis continued to be associated
with worse QOL at baseline (CSAL: -0.25 (95%-CI: -0.36; -0.14, p<0.001), EQ-5D: -0.03 (95%-
CI: -0.05; -0.02, p<0.001)) and at follow-up (CSAL: -0.13 (95%-CI: -0.24; -0.02, p = 0.02), EQ-
5D: -0.02 (95%-CI: -0.03; -0.00, p = 0.03)). Likewise, increasing frailty continued to be associ-
ated with a decrease in QOL at baseline and follow-up when multivariably adjusted (Tables 2
Table 1. Sample characteristics of the respondents with versus without cancer.
People without cancer People with cancer p-value
n Mean ± SD / % n Mean ± SD / %
Age 6736 78.6 ± 6.4 751 79.1 ± 6.5 0.05
Sex (% female) 6742 4006 (59.4%) 751 373 (49.7%) <0.001
Education level 6683 745 0.99
Low 3248 (48.6%) 361 (48.5%)
Moderate 2641 (39.5%) 296 (39.7%)
High 794 (11.9%) 89 (11.8%)
CSAL (T0) 6628 7.2 ± 1.5 743 6.9 ± 1.4 <0.001
CSAL (T12) 5974 7.1 ± 1.5 648 6.8 ± 1.4 <0.001
EQ-5D (T0) 6639 0.77 ± 0.2 740 0.73 ± 0.2 <0.001
EQ-5D (T12) 5936 0.76 ± 0.2 648 0.71 ± 0.3 <0.001
TOPICS-FI38 (T0) 6717 0.20 ± 0.13 716 0.23 ± 0.13 <0.001
Education level: education levels as defined by Verhage[30] were classified as low (ranging from less than 6 years primary school to vocational school),
moderate (ranging from secondary professional education to university entrance level) and high (university or tertiary education). CSAL: Modified Cantril’s
Self Anchoring Ladder, range 0 to 10, where 10 indicates the best score for present life as rated by individuals. EQ-5D: EuroQol-5D utility score, range -0.33
to 1.00 where a score below zero is indicative of a health state worse than death. TOPICS-FI38: TOPICS-MDS frailty index consisting of 38 items to
quantify frailty, range 0 to 1, where participants with a score equal to or above 0.25 are considered to be frail. T0 indicates the baseline measurement, T12
indicates the measurement after 12 months.
https://doi.org/10.1371/journal.pone.0189648.t001
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and 3). Per 0.1 increase on the frailty index, the CSAL score decreased with 0.35 (95%-CI: 0.32–
0.38, p<0.001) and the EQ-5D score decreased with 0.12 (95%-CI: 0.11–0.12, p<0.001) at base-
line. At follow-up, the CSAL score decreased with 0.27 (95%-CI: 0.24–0.30, p<0.001) per 0.1
increase on the frailty index and the EQ-5D score with 0.07 (95%-CI: 0.06–0.07, p<0.001).
When mutually adjusting for frailty and a cancer diagnosis, parameter estimates for the
strength of the associations between a cancer diagnosis and types of QOL diminished
Fig 3. Heat map presenting the proportions of frailty deficits in frail* respondents with versus without
cancer. The proportions in frailty deficits per item among older frail people with and without cancer were
graphically represented as colors. The higher the proportion, the higher the color intensity. In addition,
percentages of participants with the deficit endorsed were also shown. * Cut-off point for frail people:
TOPICS-FI38 0.25.
https://doi.org/10.1371/journal.pone.0189648.g003
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considerably and only remained significant for CSAL at baseline (-0.14 (95%-CI: -0.25; -0.03),
p<0.05). Vice versa, the strength of the associations between frailty and QOL diminished
much less and remained significant for all QOL outcomes at baseline (CSAL: -0.35 (95%-CI:
-0.38; -0.32), EQ-5D: -0.12 (95%-CI: -0.12; -0.11)) and follow-up (CSAL: -0.27 (95%-CI: -0.30;
-0.24), EQ-5D: -0.07 (95%-CI: -0.07;-0.06)). The interaction term frailtycancer diagnosis was
neither significant for QOL scores at baseline nor for QOL scores at follow-up.
Discussion
The purpose of this study was to examine the association between frailty and cancer in their
combined impact on self-perceived and health-related QOL in community-dwelling older
people aged 65 years or above. We showed that older people with cancer were more frail than
Table 2. Associations of baseline frailty, cancer and their interaction with CSAL score at baseline and follow-up.
Determinants in
modela
CSAL at baseline (T0) CSAL at follow-up (T12)
Estimates (95% CI) Estimates (95% CI)
Cancer (yes vs.
no)
Frailty index (per 0.10
increase)
Cancer*frailty
index
Cancer (yes vs.
no)
Frailty index (per 0.10
increase)
Cancer*frailty
index
Cancer -0.25 (-0.36;
-0.14)b
-0.13 (-0.24;
-0.02)
Frailty -0.35 (-0.38; -0.32)b -0.27 (-0.30; -0.24)b
Cancer, frailty -0.14 (-0.25;
-0.03)
-0.35 (-0.38; -0.32)b -0.05 (-0.16;
0.06)
-0.27 (-0.30; -0.24)b
Cancer, frailty,
cancer*frailty
-0.12 (-0.23;
-0.01)
-0.34 (-0.37; -0.31)b -0.08 (-0.16; 0.01) -0.05 (-0.16;
0.05)
-0.27 (-0.30; -0.24)b 0.02 (-0.06; 0.11)
aAll models presented were adjusted for age, gender and education (cross-sectional) and for age, gender, education and baseline CSAL score
(longitudinal).
bP-value is below 0.001.
P-values below 0.05 are in bold.
https://doi.org/10.1371/journal.pone.0189648.t002
Table 3. Associations of baseline frailty, cancer and their interaction with EQ-5D score at baseline and follow-up.
Determinants in
modela
EQ-5D at baseline (T0) EQ-5D at follow-up (T12)
Estimates (95% CI) Estimates (95% CI)
Cancer (yes vs.
no)
Frailty index (per 0.10
increase)
Cancer*frailty
index
Cancer (yes vs.
no)
Frailty index (per 0.10
increase)
Cancer*frailty
index
Cancer -0.03 (-0.05;
-0.02)b
-0.02 (-0.03;
-0.00)
Frailty -0.12 (-0.12; -0.11)b -0.07 (-0.07; -0.06)b
Cancer, frailty 0.01 (-0.01;
0.02)
-0.12 (-0.12; -0.11)b -0.00 (-0.02;
0.01)
-0.07 (-0.07; -0.06)b
Cancer, frailty,
cancer*frailty
0.01 (-0.00;
0.02)
-0.12 (-0.12; -0.11)b -0.01 (-0.01; 0.00) -0.00 (-0.02;
0.01)
-0.07 (-0.07; -0.06)b 0.01 (-0.01; 0.02)
aAll models presented were adjusted for age, gender and education (cross-sectional) and for age, gender, education and baseline EQ-5D score
(longitudinal).
bP-value is below 0.001. P-values below 0.05 are in bold.
https://doi.org/10.1371/journal.pone.0189648.t003
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people without cancer and that the type of frailty differed. Cancer negatively affected QOL of
older people cross-sectionally and longitudinally, which was to a large extent associated with
higher frailty levels of people with cancer. Irrespective of cancer diagnosis, frailty was indepen-
dently associated with lower patient-reported QOL at baseline as well as after 12 months, both
subjectively rated and concerning health-related QOL.
Comparison with existing literature
Previous research in oncology care mainly focused on health-related QOL among patients
with specific cancer types[17, 31]. Few studies focused on QOL in older cancer patients[16].
Frailty in geriatric oncology reports is mainly evaluated for its relation with the ability of
patients to tolerate cancer treatment in terms of morbidity and survival, not for its direct rela-
tionship with QOL outcomes of care. We identified that cancer negatively affects QOL of older
people, which to a large extent may be explained by increased frailty levels. Among commu-
nity-dwelling older people, frailty was already described to be associated with worse QOL
cross-sectionally[21, 22] and over time[23, 32]. In addition, patients’ frailty has been shown to
be related with the occurrence of adverse outcomes[1–5]. Patient-reported outcomes such as
QOL seem essential in order to evaluate interventions concerning patient-centered care[33]
and personalized medicine on which current healthcare is increasingly focused[33, 34]. How-
ever, assessing and optimizing older patients’ frailty are rarely part of (evaluations of) that kind
of interventions[11]. To assess individuals’ functional impairment, physicians in oncology
care regularly use the Karnofsky performance score. The Karnofsky performance score has
been shown to be correlated with response to chemotherapy, chemotherapy tolerability and
survival[35–37] and is therefore basically used to determine the patient’s fitness for cancer
treatment. Though decreasing performance scores are also related with worse QOL[16, 31,
38], tools such as the Karnofsky performance score have relevant limitations[39]. Comprehen-
sive geriatric assessments have been shown to provide more information regarding functional
impairment than performance score measurement alone[40–44]. In other words, where the
Karnofsky performance score seems to focus on the functional impact of the cancer diagnosis
on that moment, frailty also focuses on non cancer-related vulnerability prior to or beside the
cancer diagnosis. Therefore, differences in Karnofsky performance scores may be better
understood if we do not only take into account the cancer severity, but also additional frailty
with co-morbidity[45].
Strengths and limitations
Strength of this study is the large sample size which resulted in outcomes with high ecological
validity. In addition, we used patient-reported QOL both concerning health-related QOL and
on a subjective scale in general. The cancer group was based on one question in the TOPICS-
MDS questionnaire. Misclassification might have happened, however, the accuracy of a self-
reported cancer diagnosis compared to registry data is quite high[46, 47]. We did not have
information about cancer type, stage, grade or treatment. All these factors may impact on
patients’ QOL and additionally may be related with patients’ frailty. However, we do not pre-
tend to argue that the cancer diagnosis including its severity is irrelevant[48]. We emphasize
the need to take into account patient’s frailty beside a cancer diagnosis as it may predict out-
come and thus impact on patients’ needs and goals for pre-habilitation in order to optimize
their QOL. The impossibility to include patients with missing cancer diagnosis status could be
an attrition bias, but with only a small number of missings (7%) its impact on the results is lim-
ited[49]. To finalize this section, we recognize that both the biological presence of cancer and
the psychological implications of having the disease may be linked to frailty and QOL. By the
Frailty and quality of life among older people with and without a cancer diagnosis
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use of self-reported questionnaires, however, we cannot distinguish these effects. In this study,
we did not account for ethnicity in our models though QOL will be different among ethnic
minorities. In our sample size, only 8.9% of the respondents was not native Dutch whereof
1.3% was non-Western, that made these minorities quite underrepresented. Moreover, the
TOPICS-MDS research projects greatly differ in study design, inclusion criteria, sample size
and data collection, whereby several studies targeted vulnerable or disease-specific subpopula-
tions. This may have downsized the representativeness of the sample size and caused some
selection bias. However, representativeness is not necessarily essential when examining associ-
ations[50]. Similar to other studies, ceiling effects were found for the EQ-5D utility score
reducing its discriminative ability for the most ‘healthy’ (or least frail) people. However, their
potential effect seems limited since no ceiling effects were found for Cantril’s Self-Anchoring
Ladder which had similar patterns in associations between frailty and QOL.
Practice implications
Based on this study we recommend to take into account patient’s frailty beside the cancer diag-
nosis as part of routine oncology care to be able to accurately predict natural progression of
cancer not only in terms of survival but also in terms of QOL. This enables physicians to
deliver tailor-made care and pre-habilitation options for cancer treatment based on patients’
needs. Pro-active interventions aiming to optimize older patients’ frailty may be related with
positive results for these patients[51]. In addition, since frailty was independently associated
with QOL, it can be assumed that assessing frailty should be part of evaluations of the effective-
ness of interventions based on patient-reported outcomes such as QOL.
Conclusions
Between community-dwelling older people aged 65 years or above with and without a cancer
diagnosis, differences in quality of life are explained to a large extent by differences in the
frailty levels. Therefore, non cancer-related vulnerability should be taken into account as part
of routine oncologic care. This may ultimately help to decrease the occurrence of negative out-
comes and guide treatment plans on how to optimize patients’ quality of life.
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